Company intelligence / Profile preview

Octapharma Italy

Milan, Lombardy, Italy

Ownership: Private
Employees: ~11000
Development stage: Other

Overview

Octapharma Italy is the Italian subsidiary of Octapharma AG, one of the largest human protein manufacturers in the world. The company specializes in the development and production of high-quality human proteins from human plasma and human cell lines. Its core therapeutic areas include hematology (coagulation disorders), immunotherapy (immune disorders), and critical care (bleeding management and volume substitution). Octapharma Italy manages the distribution, clinical research, and commercial operations of the group's life-saving therapies within the Italian market, supporting patients with rare and genetic conditions.

Therapeutic areas: HematologyImmunologyOtherCardiovascularNeurology
Modalities: BiologicProteinRecombinant proteinPlasma-derived therapy
Industry: Pharma

Beyond the preview

Go deeper on Octapharma Italy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Octapharma Italy.

Explore the full profile